📰 Amgen News
Page 71 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
April 26, 2024
The U.S. is set to see a surge in obesity drug introductions over the next five years. Here’s a rundown of the potential entrants.
April 26, 2024
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency...
April 26, 2024
Meritage Portfolio Management raised its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 5.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,142 shares of the medical research company’s stock after purchasing an additional […]
April 26, 2024
Amgen (AMGN) announced the imminent submission of a Marketing Authorization Application to the European Medicines Agency for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1 receptor, for the treatment of moderate to severe Thyroid Eye Disease in adults.
April 25, 2024
Women with heart disease may be prescribed cholesterol-reducing statins less frequently than men, contravening recommended treatment guidelines, according to new research released Thursday.
April 25, 2024
(Reuters) -AstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by demand for its blockbuster drugs and steady sales from partnered medicines, and sending its shares up over 5%. CEO Pascal Soriot has rebuilt the company's pipeline of new drugs since taking the helm more than a decade ago, to make blockbusters such as lung cancer drug Tagrisso, leukaemia drug Calquence and Farxiga for diabetes. Combined revenue from partnered medicines, such as...
April 25, 2024
Your investing strategies must evolve when the work-based income stops and you're living on your savings.
April 25, 2024
AZN earnings call for the period ending March 31, 2024.
April 25, 2024
Operator: Greetings and welcome to the CureVac Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.